Wright Medical Group WMGI today announced that it has
completed its acquisition of BioMimetic Therapeutics, Inc. The
transaction combines BioMimetic's breakthrough biologics platform and
pipeline with Wright's established sales force and product portfolio, to
further accelerate growth opportunities in Wright's Extremities business.
Wright previously announced plans on November 19, 2012 to acquire
BioMimetic Therapeutics, Inc. for an upfront purchase price of
approximately $190 million in cash and stock plus additional milestone
payments of up to approximately $190 million in cash, which are payable
upon receipt of FDA approval of Augment® Bone Graft and upon
achieving certain revenue milestones.
In conjunction with the closing the transaction, a
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in